Birgitta StÃ…hl
Chief Financial Officer
Medical Science
Oncopeptides
Sweden
Biography
Birgitta Ståhl was appointed CFO in 2016. Previous positions Birgitta has held include COO and acting CFO at Akinion Pharmaceuticals AB and KDev Oncology AB and Vice President Company Operations at Axelar AB, a Swedish drug development company in the field of oncology. Birgitta holds an MSc Pharm from Uppsala University and an MBA from University of Westminster in London
Research Interest
Her research interests lie in Healthcare and Medical Sciences. She is the Editor-in-Chief Member of many peer reviewed journals and her area of expertise credits her with many publications in national and international journals. She is committed to highest standards of excellence and it proves through her authorship of many books.
